[
  {
    "ts": null,
    "headline": "CVS Health Corp. stock outperforms competitors on strong trading day",
    "summary": "CVS Health Corp. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=48ec31ec59c86e97e66bb53a4176fc43f39109fdff746d5b0f3f2da3c2e45618",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760460000,
      "headline": "CVS Health Corp. stock outperforms competitors on strong trading day",
      "id": 137111187,
      "image": "",
      "related": "CVS",
      "source": "MarketWatch",
      "summary": "CVS Health Corp. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=48ec31ec59c86e97e66bb53a4176fc43f39109fdff746d5b0f3f2da3c2e45618"
    }
  },
  {
    "ts": null,
    "headline": "Goldman Sachs Initiates Coverage of CVS Health (CVS) with Buy Recommendation",
    "summary": "Goldman Sachs Initiates Coverage of CVS Health (CVS) with Buy Recommendation",
    "url": "https://finnhub.io/api/news?id=deed14857ea5ea6e1e4bd849abd2b62470370a0f15f7ea3e12e76f8a048d804a",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760459683,
      "headline": "Goldman Sachs Initiates Coverage of CVS Health (CVS) with Buy Recommendation",
      "id": 137077182,
      "image": "",
      "related": "CVS",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=deed14857ea5ea6e1e4bd849abd2b62470370a0f15f7ea3e12e76f8a048d804a"
    }
  },
  {
    "ts": null,
    "headline": "AMD upgraded, Micron downgraded: Wall Street's top analyst calls",
    "summary": "AMD upgraded, Micron downgraded: Wall Street's top analyst calls",
    "url": "https://finnhub.io/api/news?id=2ebafd97b3f452ba76aa9b1bb83ace1e15f93b45b9a82cd00840371fa4680557",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760449459,
      "headline": "AMD upgraded, Micron downgraded: Wall Street's top analyst calls",
      "id": 137085630,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "AMD upgraded, Micron downgraded: Wall Street's top analyst calls",
      "url": "https://finnhub.io/api/news?id=2ebafd97b3f452ba76aa9b1bb83ace1e15f93b45b9a82cd00840371fa4680557"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer Admits He Was Wrong About CVS Health’s (CVS) Aetna",
    "summary": "We recently published Jim Cramer Discussed These 11 Stocks & The Market’s 3rd Bull Run Anniversary. CVS Health Corporation (NYSE:CVS) is one of the stocks Jim Cramer recently discussed. CVS Health Corporation (NYSE:CVS) is one of the largest healthcare services and pharmacy companies in the US. The firm scored a major win last week when […]",
    "url": "https://finnhub.io/api/news?id=41c050b1e3591e065764f68e0f7a0e1b074106953d69da5195872de5cae70c0e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760446724,
      "headline": "Jim Cramer Admits He Was Wrong About CVS Health’s (CVS) Aetna",
      "id": 137085641,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "We recently published Jim Cramer Discussed These 11 Stocks & The Market’s 3rd Bull Run Anniversary. CVS Health Corporation (NYSE:CVS) is one of the stocks Jim Cramer recently discussed. CVS Health Corporation (NYSE:CVS) is one of the largest healthcare services and pharmacy companies in the US. The firm scored a major win last week when […]",
      "url": "https://finnhub.io/api/news?id=41c050b1e3591e065764f68e0f7a0e1b074106953d69da5195872de5cae70c0e"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health® 2025 Rx Report highlights transformation of community pharmacy to meet patient needs",
    "summary": "CVS Health® (NYSE: CVS) today released the 2025 Rx Report: Community Pharmacy Reimagined, which explores how community pharmacies are adapting to meet patient demand while supporting pharmacy teams and addressing industry challenges with sustainable models of care.",
    "url": "https://finnhub.io/api/news?id=cf7faad6b04beba3cad250403784e71d1476b180678b5ef693a2262b4ea16d91",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760443200,
      "headline": "CVS Health® 2025 Rx Report highlights transformation of community pharmacy to meet patient needs",
      "id": 137086029,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health® (NYSE: CVS) today released the 2025 Rx Report: Community Pharmacy Reimagined, which explores how community pharmacies are adapting to meet patient demand while supporting pharmacy teams and addressing industry challenges with sustainable models of care.",
      "url": "https://finnhub.io/api/news?id=cf7faad6b04beba3cad250403784e71d1476b180678b5ef693a2262b4ea16d91"
    }
  },
  {
    "ts": null,
    "headline": "1 Healthcare Stock to Research Further and 2 We Find Risky",
    "summary": "Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, limiting growth. This has capped returns as the industry’s six-month gain of 8.6% has lagged the S&P 500’s 22.9% climb.",
    "url": "https://finnhub.io/api/news?id=76a94b44f60a66afa0c94d601551a8e4924ca352f779f40df076c43c7db81684",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760416553,
      "headline": "1 Healthcare Stock to Research Further and 2 We Find Risky",
      "id": 137086030,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, limiting growth. This has capped returns as the industry’s six-month gain of 8.6% has lagged the S&P 500’s 22.9% climb.",
      "url": "https://finnhub.io/api/news?id=76a94b44f60a66afa0c94d601551a8e4924ca352f779f40df076c43c7db81684"
    }
  }
]